Surgery for stage IIIa‐N2 non‐small cell lung cancer

Cancer

Volumn 73, Issue 10, 1994, Pages 2589-2598

  Mountain, Clifton F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

end results; imaging; invasive diagnostic techniques; N2 disease; non small cell lung cancer; patient selection; surgical treatment

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; HUMAN; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0028242303     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19940515)73:10<2589::AID-CNCR2820731021>3.0.CO;2-X     Document Type: Article

References (46)

1. Surgical treatment for higher stage lung cancer
2. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population
3. Statistical methods for survival time studies
4. A computer program for comparing K samples with right‐censored data
5. A computer program for estimating survival function from the life table
6. Modern thirty‐day operative mortality for surgical resections in lung cancer
7. Surgical treatment of lung cancer: consensus and controversy
8. A new international staging system for lung cancer
9. Lung
10. Lung tumors (ICDO‐0162)
11. Lymph node mapping and curability of various levels of metastasis in resected lung cancer
12. The radiologic staging of lung cancer
13. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer
14. Current applications of imaging procedures in the patient with lung cancer
15. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling
16. Value of CT in the preoperative assessment of lung cancer: a survey of thoracic surgeons
17. CT and MR imaging in staging non‐small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group
18. Bronchogenic carcinoma: staging with MR compared with staging with CT and surgery
19. Coronal magnetic resonance imaging of the chest: normal and abnormal
20. Flexible transbronchial needle aspiration for staging bronchogenic carcinoma
21. Transbronchial needle aspiration in clinical practice
22. Utility of the wang 18‐gauge transbronchial histology needle in the staging of bronchogenic carcinoma
23. Bronchoscopic and roentgenographic correlates of a positive transbronchial needle aspiration in the staging of lung cancer
24. Special report: video endo‐scopic thoracic surgery
25. Advances in surgical staging and therapy of non‐small cell lung cancer
26. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT
27. The role of mediastinoscopic biopsy in preoperative assessment of lung cancer
28. The value of selective mediastinoscopy in predicting resectability of patients with bronchogenic carcinoma
29. Mediastinoscopy: a method for inspection and tissue biopsy in the superior mediastinum
30. Diagnostic anterior mediastinotomy
31. Extended cervical mediatinoscopy: a single staging procedure for bronchogenic carcinoma of the left upper lobe
32. Combined cervical and left parasternal mediastinoscopy for preoperative staging of left upper lobe lung cancer
33. Management of Stage III disease: mediastinal adenopathy—the N2 lesion
34. The significance of ipsilateral mediastinal lymph node metastasis (N2) disease in non‐small cell carcinoma of the lung
35. Management of Stage III disease: alternate approaches to the management of mediastinal adenopathy
36. Surgical treatment of patients with nonsmall‐cell lung cancer and mediastinal lymph node involvement
37. Aggressive surgical intervention in N2 non‐small cell cancer of the lung
38. Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases
39. Surgical treatment of lung cancer
40. Surgery for non‐small cell lung cancer
41. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus
42. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging
43. Prognosis and survival in resected lung carcinoma based on the new international staging system
44. Surgical adjuvant therapy of Stage II and Stage III adenocarcinoma and large cell undifferentiated carcinoma
45. Clinical staging of primary lung cancer
46. Prognostic significance of computed tomography in resected N2 lung cancer